Abstract
Lipoxins (LXs) represent a class of arachidonic acid (AA) metabolites that carry potent immunoregulatory and anti-inflammatory properties, LXA4 and LXB4 being the main components of this series. LXs are generated by cooperation between 5-lipoxygenase (LO) and 12- or 15-LO during cell-cell interactions or by single cell types. LX epimers at carbon 15, the 15-epi-LXs, are formed by aspirin-acetylated cyclooxygenase-2 (COX-2) in cooperation with 5-LO. 15-epi-LXA4 is also termed aspirin-triggered LX (ATL). In vivo studies with stable LX and ATL analogs have established that these eicosanoids possess potent anti-inflammatory activities. A LXA4 receptor has been cloned. It belongs to the family of chemotactic receptors and clusters with formyl peptide receptors on chromosome 19. Therefore, it was initially denominated formyl peptide receptor like 1 (FPRL1). This receptor binds with high affinity and stereoselectivity LXA4 and ATL. It also recognizes a variety of peptides, synthetic, endogenously generated, or disease associated, but with lower affinity compared to LXA4. For this reason, this receptor has been renamed ALX. This review summarizes the current knowledge on ALX expression, signaling, and potential pathophysiological role. The involvement of additional recognition sites in LX bioactions is also discussed.
Highlights
Lipoxin ReceptorsReceptor-mediated activation of these cell types yields significant accumulation of LXA4 and LXB4[1]
Lipoxins (LXs) represent a class of arachidonic acid (AA) metabolites with unique anti-inflammatory and immunoregulatory properties
Studies with recombinant platelet 12-LO showed that this enzyme has a high affinity for LTA4, comparable to that calculated for AA, indicating that LX synthase may represent a major activity of platelet 12-LO[4]
Summary
Receptor-mediated activation of these cell types yields significant accumulation of LXA4 and LXB4[1] This route proceeds through conversion of the 5-LO product leukotriene (LT) A4, derived from activated PMNs, into LXs by the platelet 12-LO[2]. Studies with recombinant platelet 12-LO showed that this enzyme has a high affinity for LTA4, comparable to that calculated for AA (apparent Km = 7.9 ± 0.8 and 6.2 ± 1.8 μM, respectively), indicating that LX synthase may represent a major activity of platelet 12-LO[4] In vivo, this pathway is likely to occur during coronary angioplasty[5] and following strenuous exercise[6], when interactions between PMNs and platelets have been documented.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
